The cost of supplies and operating expenses have risen sharply, putting pressure on profits. That has prompted more farms to ...

The US Department of Justice (DOJ) recently issued a final order (the Order) immediately rescheduling certain marijuana-related products from ...

While Zatolmilast demonstrated an efficacy signal in one study in adults, the drug missed its primary endpoints across the FXS programme.

A considerable number of U.S. adults report microdosing psychoactive substances in their lifetime, according to a study ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with ...

The commencement of DReAMzz represents a major operational and strategic milestone for the Company as it advances IHL-42X toward late-stage clinical development and potential registration pathways.

Older adults in Colorado were drawn to edible cannabis mainly to manage sleep problems, pain, anxiety, or depression, often ...

Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.

Have you ever heard of CBD? With its growing popularity, it’s likely you’ve seen or heard about CBD products ranging from ...

Researchers have developed a hemp-derived plastic alternative that could minimize the negative environmental impacts of ...

Trump Urges Congress to Update Law to Ensure Access to Cannabidiol Products April ⁠23 (Reuters) - ⁠U.S. ⁠President Donald Trump ‌in ‌a ⁠Truth Social ⁠post on Thursday called on ⁠Congress ⁠to ⁠update ...